Severe Hypoxemia in a Young Patient: Unusual Presentation of Cryptogenic Cirrhosis with Hepatopulmonary Syndrome
Abstract
Cirrhosis can cause changes in micro-vasculature of any bodily system; when it involves pulmonary arteries, impaired gas exchange takes place due to increased production of vasodilatory substances like nitric oxide, vessel remodeling and angiogenesis, resulting in hypoxemia. We are reporting a case of a 35-year-old woman who presented to emergency department with bluish discoloration of her fingertips and exertional dyspnea, with no known prior liver disease. Examination revealed SpO levels of 60% via pulse oximetry at room air, palmar erythema, digital clubbing and 2 splenomegaly. Further evaluation revealed an A-a gradient of 66mmHg and contrast echocardiography confirmed intra pulmonary shunt, but no etiology of chronic liver disease was identified. Imaging confirmed cirrhosis, which was labelled cryptogenic, along with evidence for portal hypertension. She was diagnosed with Hepatopulmonary Syndrome (HPS) and was referred to liver transplant medicine based on MELD exception criteria. This case signifies the importance of considering HPS in any patient with unexplained hypoxemia and suspected chronic liver disease. Importance of MELD exception criteria is also highlighted for this patient as liver transplant remains the only treatment for HPS at the moment.
How to Cite This Article
Ahmed H, Malik MN, Harem H, Qaisar W, Khan I. Severe Hypoxemia in a Young Patient: Unusual Presentation of Cryptogenic Cirrhosis with Hepatopulmonary Syndrome. J Pak Soc Intern Med. 2025;6(3):284–286. doi:10.70302/jpsim.v6i3.2553
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Raevens S, Geerts A, Devisscher L, Van Vlierberghe H, Van Steenkiste C, Colle I. Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension. Acta Gastro-Enterol Belg. 2021;84(1):95-9.
- Bilal S, Khan M, Leeza S, Farrukh GM, Izhar S, Ramzan MA. Frequency of Hepatopulmonary Syndrome and its Associated Factors in Decompensated Liver Cirrhosis. Pak J Chest Med. 2022;28(1):20-5
- Raevens S, Boret M, Fallon MB. Hepatopulmonary syndrome. JHEP Reports. 2022 Sep 1;4(9):100527.
- Younis I, Sarwar S, Butt Z, Tanveer S, Qaadir A, Jadoon NA. Clinical characteristics, predictors, and survival among patients with hepatopulmonary syndrome. Ann Hepatol. 2015;14(3):354-60.
- Han SK, Kim MY, Kang SH, Suk KT, Baik SK. Hepatopulmonary syndrome is related to the development of acute-on-chronic liver failure and poor prognosis in cirrhotic patients. Hepatol Int. 2021 Oct;15(5):1207-14.
- Cosarderelioglu C, Cosar AM, Gurakar M, Dagher NN, Gurakar A. Hepatopulmonary syndrome and liver transplantation: a recent review of the literature. J Clin Transl Hepatol. 2016;4(1):47.
- Dogar AW, Ullah K, Ochani S, Ahmad HB. Evolving liver transplantation in Pakistan: future challenges. Ann Med Surg. 2022;82:104669.
- Lai Y, Hung HC, Lee JC, Wang YC, Cheng CH, Wu TH, et al. Hepatopulmonary Syndrome and Liver Transplantation: Impact on Survival and Postoperative Complications. Annals of Transplantation. 2024;29:e945297.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.